Amyotrophic Lateral Sclerosis Industry to 2023

1
EpiCast Report Amyotrophic Lateral Sclerosis
Epidemiology Forecast to 2023
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_marketoptimizer.org with
your contact details and questions if any.

• Published May 2014
• Single User PDF US 2500
• Corporate User PDF US 7500

2
EpiCast Report Amyotrophic Lateral Sclerosis
Epidemiology Forecast to 2023

• Amyotrophic lateral sclerosis (ALS), often
  referred to as Lou Gehrigs Disease, is a rare,
  but fatal, progressive neurodegenerative disease
  that affects the nerve cells in the brain and the
  spinal cord. ALS severely impacts physical
  functioning and initially presents with muscle
  twitching, weakness in an arm or leg, or with
  slurring of speech. Eventually, people with ALS
  lose their ability to control the muscles needed
  to move, speak, eat, and breathe, which
  ultimately leads to death. The progressively
  degenerative course of the condition is a great
  burden for both patients and caregivers, as well
  as for society.
• Researcher epidemiologists forecast that the
  diagnosed prevalent cases of ALS in the 7MM will
  grow by 13.5 over the next decade, from 32,698
  diagnosed prevalent cases in 2013 to 37,122
  diagnosed prevalent cases in 2023. Throughout the
  forecast period, the US will have the highest
  numbers of diagnosed prevalent cases of ALS,
  followed by Japan.
• Inquire about this report at http//www.marketopti
  mizer.org/contacts/purchase?rname7052

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
3
EpiCast Report Amyotrophic Lateral Sclerosis
Epidemiology Forecast to 2023

• To develop the epidemiological forecast for the
  diagnosed prevalent cases of ALS in the 7MM,
  Researcher epidemiologists obtained the diagnosed
  prevalence data for ALS from peer-reviewed
  journals and population-based studies in the
  respective markets and used a consistent
  methodology to ensure comparability of the
  results. A major strength of Researchers
  epidemiological analysis is the use of
  country-specific studies that provided the
  diagnosed prevalence of ALS using uniform
  diagnostic criteria based on the El Escorial
  criteria or the International Classification of
  Diseases, Ninth Revision (ICD-9), criteria (ICD-9
  code for ALS 335.2), to allow for a meaningful
  comparison of the diagnosed prevalent cases of
  ALS in these markets. Furthermore, the diagnosed
  prevalent cases of ALS in each of the 7MM were
  further segmented by age and sex in order to
  provide a more detailed analysis of the patient
  population.

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
4
EpiCast Report Amyotrophic Lateral Sclerosis
Epidemiology Forecast to 2023

• Scope
• The Amyotrophic lateral sclerosis (ALS) EpiCast
  Report provides an overview of the risk factors,
  comorbidities, and the global and historical
  trends for ALS in the seven major markets (7MM)
  (US, France, Germany, Italy, Spain, UK, and
  Japan). It includes a 10-year epidemiological
  forecast for the diagnosed prevalent cases of ALS
  segmented by age (40 years) and sex in these
  markets.
• The ALS epidemiology report is written and
  developed by Mastersand PhD-level
  epidemiologists.
• The EpiCast Report is in-depth, high quality,
  transparent and market-driven, providing expert
  analysis of disease trends in the 7MM.
• Get a detailed report at http//www.marketoptimiz
  er.org/epicast-report-amyotrophic-lateral-sclerosi
  s-epidemiology-forecast-to-2023.html .

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
5
EpiCast Report Amyotrophic Lateral Sclerosis
Epidemiology Forecast to 2023

• Reasons to buy
• Develop business strategies by understanding the
  trends shaping and driving the global ALS market.
• Quantify patient populations in the global ALS
  market to improve product design, pricing, and
  launch plans.
• Organize sales and marketing efforts by
  identifying the sex and age groups that present
  the best opportunities for ALS therapeutics in
  each of the markets covered.
•  
•  
• Contact sales_at_marketoptimizer.org with subject
  line EpiCast Report Amyotrophic Lateral
  Sclerosis Epidemiology Forecast to 2023 and
  your contact details to purchase this report or
  get your questions answered. OR Call 1 888 391
  5441.

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
6
EpiCast Report Amyotrophic Lateral Sclerosis
Epidemiology Forecast to 2023

• About Us
• marketoptimizer.org is an online market research
  reports library of 250,000 in-depth studies of
  over 5000 micro markets. Our database includes
  reports by leading publishers from across the
  globe. We provide 24/7 online and offline support
  service to our customers. marketoptimizer.org
  also offers company data, country profiles,
  trends, information and analysis on the sector of
  your interest.
• Visit Us _at_
• http//www.marketoptimizer.org
• Follow Us

Call Now 1 888 391 5441 Email sales _at_
sales_at_marketoptimizer.org